Researcher is exploring safer and more effective treatment for leukemia – News-Medical.Net
stemadminAdult Stem CellsNo comments

A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences. The procedure is known as a haploidentical (half-matched) bone marrow transplantation, or "haplo-BMT," providng an alternative source of stem cells for patients who need a bone marrow transplant but are unable to find a perfect or near-perfect donor match for human leukocyte antigens (HLA)

Read more
‘Self-eating’ stem cell process may be the key to new regenerative therapies – Penn Today
stemadminAdult Stem CellsNo comments

The self-eating process in embryonic stem cells known as chaperone-mediated autophagy (CMA) and a related metabolite may serve as promising new therapeutic targets to repair or regenerate damaged cells and organs,Penn Medicineresearchers show in a new study published online inScience. Human bodies contain more than 200 different types of specialized cells. All of them can be derived from embryonic stem (ES) cells, which relentlessly self-renew while retaining the ability to differentiate into any cell type in adult animals, a state known as pluripotency.

Read more
Potential COVID-19 cell therapy treatments in development – BioWorld Online
stemadminAdult Stem CellsNo comments

Biopharma companies that are focused on cell therapies have reported promising clinical trial results in their ability to treat acute respiratory distress syndrome (ARDS), a condition that has shown to be a significant contributor to higher mortality in COVID-19 cases. In an Alliance for Regenerative Medicine (ARM) webinar on the topic, Michael Lehmicke, director, science and industry affairs at ARM, noted that developers are utilizing mesenchymal stem cells (MSCs) and other stromal cells to treat ARDS caused by COVID-19. The number of clinical trials now underway continues to increase with many more at the preclinical stage

Read more
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update – PRNewswire
stemadminAdult Stem CellsNo comments

NEW YORK, July 27, 2020 /PRNewswire/ --BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2020, and provide a corporate update, at 8:00 a.m., Eastern Daylight Time (EDT), on Wednesday, August 5 2020.

Read more
Stem Cells Market Study for 2020 to 2026 Providing Information on Key Players, Growth Drivers and Industry Challenges|CCBC, Vcanbio, Boyalife – Owned
stemadminAdult Stem CellsNo comments

QY Research has Published Latest Trending Report on Global Stem Cells Market Los Angeles, United State, The report titledGlobal Stem Cells Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Stem Cells market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Stem Cells market

Read more
Stem Cell Therapy Market Research Outlook, Recent Trends and Growth Forecast 2020-2025 – Bulletin Line
stemadminAdult Stem CellsNo comments

The Stem Cell Therapy report provides independent information about the Stem Cell Therapy industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porters five force analysis, and key companies profiles including business overview and recent development.

Read more

Theme: Illdy.